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Leishmaniasis is a neglected disease,
and yet, since the early 1990s, the disease has spread
significantly, both in endemic tropical regions and also in
more temperate climates. An estimated 350 million people
are at risk from infection around the world, and 12 million are
believed to be infected1. In Europe, cases of the more
deadly, ‘visceral’ form of the disease are being reported
among intravenous drug users with HIV, where infection
occurs in the absence of an insect vector.
Many available drugs against these types of parasite
have toxic side effects, resulting in deaths of up to one in 10.
Until recently, the search for safe and effective treatments
has been hampered by the conservation of biochemical
processes between parasitic protozoa and their human
hosts. Now, Dr Paul Denny and colleagues at the Centres for
Infectious Diseases and Bioactive Chemistry at Durham
University have identified and characterised a protozoan
enzyme that catalyses the production of an essential cell
membrane component – a ‘complex sphingolipid’.
Sphingolipids are ubiquitous components of all
eukaryotic membranes: protozoa, fungi, plants and animals.
The biosynthetic pathway is conserved up to the formation
of a substance called sphinganine, but then the pathway
splits. Unlike mammalian cells, which go on to produce
sphingomyelin, the primary membrane sphingolipid in plants
and fungal species is inositol phosphorylinositol (IPC). IPC
synthesis also occurs in protozoa, although its precise role in
pathogenesis is unclear.
The gene encoding the IPC synthase enzyme in fungi,
AUR1, was first identified in the model organism
Saccharomyces cerevisiae. “Using this yeast model, we have
developed a screening assay to identify related genes in
Leishmania and other parasites,” explains Dr Denny. “Not
only have we identified a protozoan IPC synthase gene, we
have also identified an inhibitor with specific activity against
this enzyme”  
Their system, for which the team recently filed a patent,
has many benefits in the search for non-toxic anti-protozoan
drugs. “Potentially we can rapidly screen thousands of
compounds for inhibitory effects against the IPC enzyme
using our multi-well plate assay; and because it is a yeast-
based system, it avoids the expense and time involved in
growing these pathogenic protozoa in contained laboratory
facilities,” says Dr Denny.
Working with Dr Patrick Steel, a synthetic chemist, and
Dr Ehmke Pohl, a structural biologist, the next step is to
understand the structure and mechanism of the enzyme. This
work will inform rational drug design.  
Scientists at Durham University have developed a screening system,
which promises to help in the fight against tropical diseases such as
Leishmaniasis and African Sleeping Sickness. Already they have
identified and characterised a protozoan enzyme, with no mammalian
equivalent, raising the possibility of new drugs with reduced side effects.
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Leishmania parasite showing
the site of IPC synthesis (red).
